Lisa Carroll, a 47-year-old mother of three from Coventry, received a diagnosis of mucinous ovarian cancer (MOC) after returning from a family holiday. Initially, she believed her symptoms were related to irritable bowel syndrome, a kidney infection, or another minor condition. Upon seeking medical advice through NHS 111, she was directed to a hospital in Coventry, where scans identified a 12-centimeter cyst on her right ovary that initially did not appear particularly concerning to medical staff.
The cyst expanded rapidly over the following weeks. Within a month, it had grown to the size of a fist, and by December, imaging revealed the tumour had increased to 20 centimeters and was beginning to rupture. Carroll underwent emergency surgery to remove the tumour, a fallopian tube, her appendix, and surrounding tissue. Two weeks after the procedure, she received her cancer diagnosis. According to Ovacome, an ovarian cancer charity, approximately 200 cases of this exceptionally rare cancer are diagnosed annually in the UK.
Carroll underwent extensive treatment including chemotherapy, which resulted in hair loss and triggered early menopause. She described the menopausal symptoms as particularly challenging, as they complicated her ability to distinguish between cancer-related symptoms and hormonal changes. She experienced hot flushes, emotional instability, memory difficulties, and impaired ability to perform routine household tasks.
Today, Carroll is cancer-free and approaching a five-year milestone that will formally mark her discharge from oncology care. She has become involved with Ovacome and credits the organization with providing crucial emotional support during her treatment journey. Carroll is participating in the charity’s annual fundraising walk to raise awareness about ovarian cancer and encourage others to seek medical attention when they experience concerning symptoms. The walk takes place at Cannon Hill Park in Birmingham.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI